pirinixic acid has been researched along with Alzheimer Disease in 2 studies
pirinixic acid: structure
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corbett, GT | 1 |
| Gonzalez, FJ | 1 |
| Pahan, K | 1 |
| Pohland, M | 1 |
| Hagl, S | 1 |
| Pellowska, M | 1 |
| Wurglics, M | 1 |
| Schubert-Zsilavecz, M | 1 |
| Eckert, GP | 1 |
2 other studies available for pirinixic acid and Alzheimer Disease
| Article | Year |
|---|---|
Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Topics: ADAM Proteins; ADAM10 Protein; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precur | 2015 |
MH84: A Novel γ-Secretase Modulator/PPARγ Agonist--Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; HEK293 Cells; Humans; Mitochondria; Models, | 2016 |